Search

Your search keyword '"Schwartz, Cindy L."' showing total 476 results

Search Constraints

Start Over You searched for: Author "Schwartz, Cindy L." Remove constraint Author: "Schwartz, Cindy L."
476 results on '"Schwartz, Cindy L."'

Search Results

6. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia

7. Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children

8. Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031

9. The Thyroid Gland

15. Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer

17. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

18. The Thyroid Gland

26. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Childrenʼs Oncology Group (COG AHOD0031) comparative analysis

27. Overview

28. Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031.

29. Outcomes of patients with bilateral retinoblastoma: A report from the RIVERBOAT Consortium.

30. Outcomes of patients with unilateral retinoblastoma: A report from the RIVERBOAT Consortium.

32. Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group

34. Osteosarcoma

38. The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

39. Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group

41. A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Childrenʼs Oncology Group study

43. Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate‐risk Hodgkin lymphoma treated with chemo‐radiation therapy: FDG‐PET parameter analysis in a subgroup from COG AHOD0031

44. ACR Appropriateness Criteria® Pediatric Hodgkin Lymphoma

47. Pediatric classical Hodgkin lymphoma

49. Chronic health conditions in adult survivors of childhood cancer

50. Survival Differs by Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Catalog

Books, media, physical & digital resources